Met Life Investment Management, LLC Eton Pharmaceuticals, Inc. Transaction History
Met Life Investment Management, LLC
- $16.5 Billion
- Q2 2025
A detailed history of Met Life Investment Management, LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 15,537 shares of ETON stock, worth $288,522. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,537Holding current value
$288,522% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ETON
# of Institutions
90Shares Held
15MCall Options Held
242KPut Options Held
11.8K-
Opaleye Management Inc. Boston, MA2.86MShares$53.1 Million9.75% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.03MShares$37.7 Million2.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$24.4 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$21.8 Million0.73% of portfolio
-
Geode Capital Management, LLC Boston, MA593KShares$11 Million0.0% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $470M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...